Catalog
Peptide signaling.
Growth-hormone pathway peptides with straightforward pricing.
Starting at
$89
A two-compound GH-axis stack pairing CJC-1295 without DAC with Ipamorelin for coordinated GHRH and GHS-R1a pathway coverage.
Starting at
$39
A tetrasubstituted analog of GHRH(1-29) engineered for metabolic stability. Widely used in preclinical research on pulsatile growth hormone release.
Starting at
$59
A DAC-linked GHRH analog studied for half-life extension, albumin binding, and GH-axis pathway signaling in controlled research models.
Peptide signaling
Ipamorelin
Starting at
$39
A pentapeptide growth hormone secretagogue receptor agonist developed as a research tool for selective GH release without significant cortisol or prolactin elevation in published preclinical models.
Starting at
$79
A synthetic analog of human GHRH(1-44) stabilized by N-terminal trans-3-hexenoic acid. Approved as Egrifta for HIV-associated lipodystrophy and widely studied in visceral adipose tissue research.
Starting at
$45
A 29-amino-acid amidated fragment corresponding to the active N-terminal region of growth hormone-releasing hormone, used in laboratory research on GHRH receptor signaling and pituitary GH-axis models.
Starting at
$129
A long R3 analog of insulin-like growth factor 1 used in laboratory research on IGF-1 receptor signaling, binding-protein interactions, and growth-factor pathway models.